SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Supriya Lifescience - Quaterly Results

14 Feb 2023 Evaluate
Net sales declined -10.14%  to  Rs. 1051.40 million from Rs. 1170.00 millions.A big loss of -75.99% reported for the quarter ended December 2022 to Rs. 95.17  millions from Rs. 396.39 millions.The Operating Profit of the company witnessed a decrease to 166.07 millions from 438.17 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1051.40 1170.00 -10.14 3186.67 3418.00 -6.77 5300.49 3912.45 35.48
Other Income 25.64 54.42 -52.88 75.26 107.02 -29.68 75.77 49.77 52.24
PBIDT 166.07 438.17 -62.10 1043.57 1583.13 -34.08 2215.62 1781.51 24.37
Interest 10.14 11.49 -11.75 253.50 190.10 33.35 41.98 40.80 2.89
PBDT 155.93 426.68 -63.46 790.07 1393.03 -43.28 2173.64 1740.71 24.87
Depreciation 29.50 25.99 13.51 88.08 75.39 16.83 101.18 67.61 49.65
PBT 126.43 400.69 -68.45 701.99 1317.64 -46.72 2072.46 1673.10 23.87
TAX 31.26 4.30 626.98 185.70 261.65 -29.03 554.35 437.16 26.81
Deferred Tax 7.05 -119.86 -105.88 10.96 -75.79 -114.46 32.46 6.94 367.72
PAT 95.17 396.39 -75.99 516.29 1055.99 -51.11 1518.11 1235.94 22.83
Equity 160.97 160.96 0.01 160.97 160.96 0.01 160.97 146.37 9.97
PBIDTM(%) 15.80 37.45 -57.82 32.75 46.32 -29.30 41.80 45.53 -8.20

Supriya Lifescience Share Price

636.90 -1.05 (-0.16%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×